Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
Direct to consumer genetic health tests are popular but is taking one a good idea? We brought in genetics counselor Karin Dent to explain the realities of at-home genetics testing and why it’s ...
Genetics testing company 23andMe can now tell you about your breast cancer risk — at least based on three mutations found on the BRCA1 and BRCA2 genes. Genetic counselors who help people navigate ...
Myriad Genetics, Inc.’s MYGN GeneSight pharmacogenomics test was recently rolled out with Integrated Prescription Management (IPM), a pharmacy benefits management (PBM) company. Notably, the IPM will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results